NOS2 and obesity due to melanocortin 4 receptor deficiency: Hydroxydecanoate is enhanced in obesity-associated IR and type 2 diabetes (Al-Sulaiti et al., 2019); we, similarly, observed an increase in this metabolite in iNOS−/− mice and a reduction with vancomycin intervention.